Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 832 of 1,261

  1. US 8642656

    Calixarene-based peptide conformation mimetics, methods of use, and methods of making

    Regents of the University of Minnesota · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  2. US 8642653

    Ketone compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  3. US 8637036

    Neutralizing antibodies to HIV-1 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  4. US 8637009

    Thermostabilization of proteins

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  5. US 8637239

    Minimally-invasive measurement of esophageal inflammation

    The Regents of the University of Colorado, a Body Corporate · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  6. US 8637077

    Sustained-release preparation

    Takeda Pharmaceutical Company Limited · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  7. US 8637049

    Attenuated live vaccines for aquatic animals

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  8. US 8637041

    Secreted Campylobacter flaggella coregulated proteins as immunogens

    United States of America as represented by the Secretary of the Air Force · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  9. US 8637011

    Modulation of NKG2D

    The Regents of the University of California · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  10. US 8636978

    Cyclized NGR peptide compounds, compositions, and methods of their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  11. US 8637506

    Compositions and methods for bone formation and remodeling

    UNIVERSITY OF CONNECTICUT · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  12. US 8637038

    Methods for inhibiting allograft rejection

    Rigel Pharmaceuticals, Inc. · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  13. US 8637310

    Use of a rock inhibitor to sustain primary human keratinocytes in a proliferative state

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  14. US 8637074

    Methods for co-encapsulation of combination drugs and co-encapsulated combination drug product

    Aphios Corporation · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  15. US 8637457

    Processes and intermediates

    Vertex Pharmaceuticals Incorporated · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  16. US 8636994

    Polymer-based compositions and conjugates of antimicrobial agents

    Nektar Therapeutics · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  17. US 8637079

    Solid preparation comprising alogliptin and pioglitazone

    Takeda Pharmaceutical Company Limited · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  18. US 8637013

    Treatment of drug-related side effect and tissue damage by targeting the CD24-HMGB1-Siglec10 axis

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  19. US 8637026

    Anti-C35 antibody combination therapies and methods

    VACCINEX, INC. · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  20. US 8636988

    Composition for treatment of sunburned skin

    Doctor Essentials · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  21. US 8636997

    Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  22. US 8637031

    Method of treating osteoarthritis with an antibody to NGF

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  23. US 8637675

    Inhibitors of proliferation and activation of signal transducer and activators of transcription (STATS)

    The Board of Regents of the University of Texas System · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  24. US 8637466

    Multi-arm polymeric alkanoate conjugates

    Nektar Therapeutics · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.